I-Mab Gets Boost from Latest Industry Signals on New Cancer Treatment 癌症新疗法取得突破，力推天境生物股价上涨
Company’s shares surged as much as 15% after AstraZeneca unveiled upbeat results for a new class of cancer drugs known as CD73 antibodies 在阿斯利康宣布CD73抗体的新型抗癌药物取得乐观结果后，天境生物的股价飙升15%。
Bamboo Works (official website) provides news on Chinese companies listed in Hong Kong and the United States, with a strong focus on mid-cap and also pre-IPO companies.